Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

DRUG: HAIC
DRUG: Sintilimab
DRUG: Bevacizumab Biosimilar IBI305

PHASE2

Phase

UNKNOWN

Status

Enrollment

OTHER

Sponsor class

Conditions

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology